OncoVista Innovative Therapies Inc (OVIT)

[gi197845]

Well, I would normally agree with your logic and I hope you're right. These are the reasons that I'm not 100% confident in your logic regarding new technology or a shell buy out...

1. OVIT has been dormant for several years, w/o any action.
2. Dr.Wiess is old and apparently in poor health, so he's probably unable to provide direction.
3. Cancer has basically been cured with stem cells and gene therapy, so the days of finding a simple, antic-cancerous mold that grows on cow manure, (OVI-123) are over.
4. I can't imagine, any cheap, new technology that OVIT could afford to bring in.

Reasons in favor of a shell buy out.

1. It costs approximately $5 million to incorporate a business and go public, an existing company could purchase OVITs existing shell for less.
2. A new companies technology could be for treating any condition.
3. OVIT has a low market cap, making it an attractive buyout target.
4. OVIT has a low float of shares, making it an attractive buyout target.
5. The OVIT share price is low, making it an attractive buyout target.
6. Dr.Wiess and his daughter are most likely wanting to be done with OVIT for, due to age, poor health and wanting to work for a living.

I suspect the volume in OVIT today is nothing more than a hopeful opportunist, buying shares at a low price, which is especially low now, due to the end of year tax loss selling, by frustrated investors and the buyer today is just hoping against all odds, at the biggest long shot in biotech history, of OVIT being successful with a new technology or being bought out and reinvented as a new company.